Chembio Diagnostics Inc
NASDAQ:CEMI
Chembio Diagnostics Inc
Cash from Operating Activities
Chembio Diagnostics Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Chembio Diagnostics Inc
NASDAQ:CEMI
|
Cash from Operating Activities
-$12.7m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
Haemonetics Corp
NYSE:HAE
|
Cash from Operating Activities
$197.4m
|
CAGR 3-Years
9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
|
Cooper Companies Inc
NYSE:COO
|
Cash from Operating Activities
$563.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
3%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash from Operating Activities
$377m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-1%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash from Operating Activities
$785.8m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
See Also
What is Chembio Diagnostics Inc's Cash from Operating Activities?
Cash from Operating Activities
-12.7m
USD
Based on the financial report for Dec 31, 2022, Chembio Diagnostics Inc's Cash from Operating Activities amounts to -12.7m USD.
What is Chembio Diagnostics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-20%
Over the last year, the Cash from Operating Activities growth was 59%. The average annual Cash from Operating Activities growth rates for Chembio Diagnostics Inc have been -12% over the past three years , -20% over the past five years .